Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T13:36:27.825Z.
Calculation as of: 2026-10-06T13:36:27.825Z.
Quote observation: 2026-10-06T13:30:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5811ce025d9976e80ea69b9f8bae613fc78d61205a97c72640e2bc4d521a59ba
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$53.11M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.53M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.78M
EV/Sales Ratio
159.00x
TTM Avg
123.33x
3Y Avg
165.71x
5Y Avg
999.06x
Market Cap
$51.04M
EV/Sales Ratio
N/A
TTM Avg
768.07x
3Y Avg
1353.01x
5Y Avg
2660.76x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $53.11M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | N/A | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.53M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $52.67M | N/A | 46.89x | 17.85x | 13.82x |
| Envoy Medical, Inc. (COCH)vs › | $51.78M | 159.00x | 123.33x | 165.71x | 999.06x |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $51.17M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.04M | N/A | 768.07x | 1353.01x | 2660.76x |
| biote Corp. (BTMD)vs › | $50.25M | 0.91x | 0.87x | 1.10x | 0.92x |
| Clene Inc. (CLNN)vs › | $49.84M | 317.30x | 420.85x | 206.07x | 241.56x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
